A
Amita Sharma
Researcher at Harvard University
Publications - 141
Citations - 3762
Amita Sharma is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Lung cancer. The author has an hindex of 28, co-authored 117 publications receiving 2716 citations. Previous affiliations of Amita Sharma include Northwestern University & Beth Israel Deaconess Medical Center.
Papers
More filters
Journal ArticleDOI
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease
Zachary S. Wallace,Ray Naden,Suresh T. Chari,Hyon K. Choi,Emanuel Della-Torre,Jean Francois Dicaire,Phillip A. Hart,Dai Inoue,Mitsuhiro Kawano,Arezou Khosroshahi,Marco Lanzillotta,Kazuichi Okazaki,Cory A. Perugino,Amita Sharma,Takako Saeki,Nicolas Schleinitz,Naoki Takahashi,Hisanori Umehara,Yoh Zen,John H. Stone +19 more
TL;DR: In this article, an international multispecialty group of 86 physicians was assembled by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR).
Journal ArticleDOI
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Zachary S. Wallace,Ray Naden,Suresh T. Chari,Hyon K. Choi,Emanuel Della-Torre,Jean Francois Dicaire,Phil A. Hart,Dai Inoue,Mitsuhiro Kawano,Arezou Khosroshahi,Kensuke Kubota,Marco Lanzillotta,Kazuichi Okazaki,Cory A. Perugino,Amita Sharma,Takako Saeki,Hiroshi Sekiguchi,Nicolas Schleinitz,James R. Stone,Naoki Takahashi,Hisanori Umehara,George Webster,Yoh Zen,John H. Stone +23 more
TL;DR: This work was undertaken to develop and validate an international set of classification criteria for IgG4‐RD, which can cause fibroinflammatory lesions in nearly any organ.
Journal ArticleDOI
Radiofrequency ablation of stage IA non–small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial
Damian E. Dupuy,Hiran C. Fernando,Shauna Hillman,Thomas Ng,Angelina D. Tan,Amita Sharma,William S. Rilling,Kelvin Hong,Joe B. Putnam +8 more
TL;DR: This study evaluated the 2‐year overall survival rate, adverse event rate, local control rate, and impact on pulmonary function tests for medically inoperable patients with stage IA non–small cell lung cancer undergoing computed tomography–guided radiofrequency ablation (RFA) in a prospective, multicenter trial.
Journal ArticleDOI
Radiofrequency ablation for treatment of medically inoperable stage I non-small cell lung cancer.
Michael Lanuti,Amita Sharma,Subba R. Digumarthy,Cameron D. Wright,Dean M. Donahue,John C. Wain,Douglas J. Mathisen,Jo-Anne O. Shepard +7 more
TL;DR: Radiofrequency ablation of medically inoperable early-stage lung cancer in carefully selected patients yields encouraging midterm results without significant loss of pulmonary function and local tumor progression appears related to lung tumors larger than 3 cm.
Journal ArticleDOI
Patterns of lymphadenopathy in thoracic malignancies.
Amita Sharma,Panos Fidias,L. Anne Hayman,Susanne L. Loomis,Katherine H. Taber,Suzanne L. Aquino +5 more
TL;DR: The role of radiologic imaging extends beyond initial staging and the guidance of interventions to include posttreatment assessment and the detection of recurrent disease.